Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer

2019418 citationsJournal Articlebronze Open Access

Authors

Isaac García-Murillas · Breast Cancer Now

Neha Chopra · Institute of Cancer Research

Iñaki Comino‐Méndez · Breast Cancer Now

Matthew Beaney · Breast Cancer Now

Holly Tovey · Institute of Cancer Research

Rosalind Cutts · Institute of Cancer Research

Claire Swift ·

Abstract

The findings suggest that detection of ctDNA during follow-up is associated with a high risk of future relapse of early-stage breast cancer. Prospective studies are needed to assess the potential of molecular relapse detection to guide adjuvant therapy.

Topics & Keywords

Cancer Genomics and Diagnostics Genetic factors in colorectal cancer Cancer Cells and Metastasis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA Oncology

Volume 5, Issue 10, pp. 1473-1473

DOI: 10.1001/jamaoncol.2019.1838

Field-Weighted Citation Impact: 13.67